论文信息 - A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial - 字舞流文

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

G. Rosner | A. Bardia | A. Wolff | C. Snyder | D. Hayes | Robert S. Miller | A. Blackford | V. Stearns | A. Nguyen | A. Storniolo | J. Fetting | R. Connolly | S. Jeter | S. Slater | J. Zorzi | C. Santa-Maria | N. L. Henry | K. Quinlan